Earnings Beat: Verona Pharma plc (NASDAQ:VRNA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts

Earnings Beat: Verona Pharma plc (NASDAQ:VRNA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
Verona Pharma plc (NASDAQ:VRNA) shares rose 2.5% post-annual results release, exceeding revenue expectations by 8.9%. Analysts predict a 629% revenue increase in 2025, with earnings improving. Price target raised to US$81.